Advertise on podcast: Clinical Capsules

A patient shows you a tick that's still attached. Do they need antibiotics to prevent Lyme disease, or is watchful waiting enough? In this episode, TRC Healthcare Assistant Editor and Clinical Pharmacist Gina Corley, PharmD, discusses tick bites and Lyme disease prevention and treatment. She goes over how to assess a tick bite, when a single dose of doxycycline is recommended to  prevent Lyme disease, and how treatment differs across the three stages of the disease. This is an excerpt from our July 2026 Pharmacy Essential Updates continuing education webinar series. 🏷️ Use code cc1026 at checkout for 10% off a new or upgraded subscription. ****** CE Information: None of the speakers have anything to disclose. TRC Healthcare offers CE credit for this podcast for pharmacist subscribers at our platinum level or higher and pharmacy technician subscribers. Log in to your Pharmacist’s Letter or Pharmacy Technician’s Letter account and look for the title of this podcast in the list of available CE courses. Claim Credit ****** The clinical resources related to this podcast are part of a subscription to Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights: Article: Brush Up on Tick Bites and Preventing Lyme DiseaseChart: Treatment of Lyme Disease ****** Don’t miss out! Subscribe today to stay ahead with trusted insights and tools. 🎓 Are you a student? Great news—students can access a free version of Pharmacist’s Letter. 🗪 Send us Fan Mail Email us: [email protected].  The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment.  Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here. Learn more about our product offerings at trchealthcare.com.

Your patients will be asking about a new prescription motion sickness med they saw advertised. Here’s what to tell them. In this episode, TRC Healthcare Associate Editor and Clinical Pharmacist Vickie Danaher, PharmD, discusses preventing motion sickness with today’s OTC and prescription products. She covers where the new neurokinin-1 antagonist tradipitant fits into therapy, which options are first-line, non-drug measures patients can try, and more. This is an excerpt from our July 2026 Pharmacy Essential Updates continuing education webinar series. 🏷️ Use code cc1026 at checkout for 10% off a new or upgraded subscription. ****** CE Information: None of the speakers have anything to disclose. TRC Healthcare offers CE credit for this podcast for pharmacist subscribers at our platinum level or higher and pharmacy technician subscribers. Log in to your Pharmacist’s Letter or Pharmacy Technician’s Letter account and look for the title of this podcast in the list of available CE courses. Claim Credit ****** The clinical resources related to this podcast are part of a subscription to Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights: Article: Explain How New Rx Tradipitant Stacks Up for Motion SicknessCE Course: Pharmacist’s Guide to Travel MedicineCE Course: Managing Common Travel-Related IllnessesDon’t miss out! Subscribe today to stay ahead with trusted insights and tools.  🎓 Are you a student? Great news—students can access a free version of Pharmacist’s Letter. 🗪 Send us Fan Mail Email us: [email protected].  The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment.  Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here. Learn more about our product offerings at trchealthcare.com.

Recurrent UTIs can be frustrating for patients…and challenging for healthcare teams trying to balance effective treatment with antibiotic stewardship. In this episode, TRC Healthcare Associate Editor and Clinical Pharmacist Don Weinberger, PharmD, PMSP, walks through evidence-based strategies for managing uncomplicated recurrent urinary tract infections, or UTIs, in women. He reviews first-line treatment options such as nitrofurantoin, prevention strategies including hydration and cranberry products, and provides guidance around prophylactic antibiotic use. This is an excerpt from our June 2026 Pharmacy Essential Updates continuing education webinar series. 🏷️ Use code cc1026 at checkout for 10% off a new or upgraded subscription. ****** CE Information: TRC Healthcare offers CE credit for this podcast for pharmacist subscribers at our platinum level or higher and pharmacy technician subscribers. Log in to your Pharmacist’s Letter or Pharmacy Technician’s Letter account and look for the title of this podcast in the list of available CE courses. None of the speakers have anything to disclose. Claim Credit ****** Clinical Resources from Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:  Article: Treat & Prevent Recurrent UTIs With Stewardship in MindChart: Urinary Tract InfectionsDon’t miss out! Subscribe today to stay ahead with trusted insights and tools.  🎓 Are you a student? Great news—students can access a free version of Pharmacist’s Letter. 🗪 Send us Fan Mail Email us: [email protected].  The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment.  Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here. Learn more about our product offerings at trchealthcare.com.

AI is becoming more accessible to both healthcare professionals and patients, creating new opportunities AND new risks in practice.  In this episode, TRC Healthcare Associate Editor and Clinical Pharmacist Vickie Danaher, PharmD, discusses how AI can support healthcare teams while emphasizing the continued importance of clinical judgment, verification, and patient-specific care. Learn practical strategies for using AI safely in your practice, what risks to watch for, and how to guide patients when it comes to AI-generated health information. This is an excerpt from our June 2026 Pharmacy Essential Updates continuing education webinar series. 🏷️ Use code cc1026 at checkout for 10% off a new or upgraded subscription. ****** CE Information: TRC Healthcare offers CE credit for this podcast for pharmacist subscribers at our platinum level or higher and pharmacy technician subscribers. Log in to your Pharmacist’s Letter or Pharmacy Technician’s Letter account and look for the title of this podcast in the list of available CE courses. None of the speakers have anything to disclose. Claim Credit ****** Clinical Resources from Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:  Article: Help Patients Navigate AI Medical Info SafelyArticle: Weave AI Into Your Plan for Precepting LearnersArticle: Think of AI as a Tool, NOT Your ReplacementFAQ: Artificial Intelligence in Pharmacy PracticePodcast: Rumor vs Truth Don’t miss out! Subscribe today to stay ahead with trusted insights and tools.  🎓 Are you a student? Great news—students can access a free version of Pharmacist’s Letter. 🗪 Send us Fan Mail Email us: [email protected].  The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment.  Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here. Learn more about our product offerings at trchealthcare.com.

Swimmer’s ear may sound simple, but the wrong drop can create real safety concerns. In this episode, TRC Healthcare Assistant Editor and Clinical Pharmacist Gina Corley, PharmD, reviews practical swimmer’s ear treatment considerations for healthcare teams, including how eardrum and ear tube status affect which otic drops are appropriate. She also discusses swimmer’s ear prevention strategies, along with guidance on how to administer ear drops. This is an excerpt from our June 2026 Pharmacy Essential Updates continuing education webinar series. 🏷️ Use code cc1026 at checkout for 10% off a new or upgraded subscription. ****** CE Information: TRC Healthcare offers CE credit for this podcast for pharmacist subscribers at our platinum level or higher and pharmacy technician subscribers. Log in to your Pharmacist’s Letter or Pharmacy Technician’s Letter account and look for the title of this podcast in the list of available CE courses. None of the speakers have anything to disclose. Claim Credit ****** Clinical Resources from Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:  Article: Be Ready With Recommendations for Swimmer’s EarDon’t miss out! Subscribe today to stay ahead with trusted insights and tools.  🎓 Are you a student? Great news—students can access a free version of Pharmacist’s Letter. 🗪 Send us Fan Mail Email us: [email protected].  The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment.  Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here. Learn more about our product offerings at trchealthcare.com.

A common liver disease is quietly affecting millions of Americans. Are we doing enough to catch it early? In this episode, TRC Healthcare Associate Editor and Clinical Pharmacist Sara Klockars, PharmD, explores the growing prevalence of MASLD and MASH. She reviews newly approved treatment options, including semaglutide and resmetirom, and discusses how healthcare teams can help identify, support, and manage patients throughout their care journey. This is an excerpt from our April 2026 Pharmacy Essential Updates continuing education webinar series. 🏷️ Use code cc1026 at checkout for 10% off a new or upgraded subscription. ****** CE Information: TRC Healthcare offers CE credit for this podcast for pharmacist subscribers at our platinum level or higher and pharmacy technician subscribers. Log in to your Pharmacist’s Letter or Pharmacy Technician’s Letter account and look for the title of this podcast in the list of available CE courses. None of the speakers have anything to disclose. Claim Credit ****** Clinical Resources from Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:  Article: Know the Latest MASH Treatment OptionsChart: Comparison of Drugs for Metabolic Liver DiseaseChart: GLP-1 and GIP/GLP-1 Receptor Agonist Interactive Comparison ChartDon’t miss out! Subscribe today to stay ahead with trusted insights and tools.  🎓 Are you a student? Great news—students can access a free version of Pharmacist’s Letter. 🗪 Send us Fan Mail Email us: [email protected].  The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment.  Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here. Learn more about our product offerings at trchealthcare.com.

New oral GLP-1s are changing the weight loss game. Here is what you need to know before recommending or dispensing one. In this episode, TRC Healthcare Associate Editor and Clinical Pharmacist Vickie Danaher, PharmD, discusses how orforglipron, the second oral GLP-1 agonist for weight loss, stacks up against oral semaglutide in terms of dosing, efficacy, safety, and more. This is an excerpt from our May 2026 Pharmacy Essential Updates continuing education webinar series. 🏷️ Use code cc1026 at checkout for 10% off a new or upgraded subscription. ****** CE Information: TRC Healthcare offers CE credit for this podcast for pharmacist subscribers at our platinum level or higher and pharmacy technician subscribers. Log in to your Pharmacist’s Letter or Pharmacy Technician’s Letter account and look for the title of this podcast in the list of available CE courses. None of the speakers have anything to disclose. Claim Credit ****** Clinical Resources from Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:  Article: Be Ready for the New Oral GLP-1 Agonist OrforglipronChart: GLP-1 and GIP/GLP-1 Receptor Agonist Interactive Comparison ChartChart: Comparison of Weight Loss ProductsDon’t miss out! Subscribe today to stay ahead with trusted insights and tools.  🎓 Are you a student? Great news—students can access a free version of Pharmacist’s Letter. 🗪 Send us Fan Mail Email us: [email protected].  The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment.  Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here. Learn more about our product offerings at trchealthcare.com.

GLP-1 access just changed for Medicare patients—and pharmacy teams are on the front lines. In this BONUS episode, Associate Editor and Clinical Pharmacist Vickie Danaher breaks down the new Medicare GLP-1 Bridge program—what it is, how it works, and what pharmacy teams need to know right now. Get a clear overview of which GLP-1 medications are covered, who qualifies, and how to navigate key requirements like prior authorization and claim routing. She also covers common points of confusion—like how the program differs from Medicare Part D, what the $50 copay actually means for patients, and what to watch for at the pharmacy counter. If you’re fielding questions about GLP-1 access or preparing your team for this new CMS program, this episode will help you stay ahead and avoid workflow headaches. 🏷️ Use code cc1026 at checkout for 10% off a new or upgraded subscription. ****** CE Information: TRC Healthcare offers CE credit for this podcast for pharmacist subscribers at our platinum level or higher and pharmacy technician subscribers. Log in to your Pharmacist’s Letter or Pharmacy Technician’s Letter account and look for the title of this podcast in the list of available CE courses. None of the speakers have anything to disclose. Claim Credit ****** Clinical Resources from Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:  Article: Navigate Questions About the Medicare GLP-1 BridgeChart: GLP-1 and GIP/GLP-1 Receptor Agonist Interactive Comparison ChartDon’t miss out! Subscribe today to stay ahead with trusted insights and tools.  🎓 Are you a student? Great news—students can access a free version of Pharmacist’s Letter. 🗪 Send us Fan Mail Email us: [email protected].  The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment.  Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here. Learn more about our product offerings at trchealthcare.com.

Continuous glucose monitoring is changing how diabetes is managed, and healthcare teams are at the center of helping patients use these devices safely and effectively. In this episode, TRC Healthcare Associate Editor and Clinical Pharmacist Vickie Danaher, PharmD, discusses how continuous glucose monitoring has helped improve diabetes care. She talks about how CGM devices work, which patients are good candidates, prescription vs. OTC options, and when guidelines recommend their use. This is an excerpt from our April 2026 Pharmacy Essential Updates continuing education webinar series. 🏷️ Use code cc1026 at checkout for 10% off a new or upgraded subscription. ****** CE Information: TRC Healthcare offers CE credit for this podcast for pharmacist subscribers at our platinum level or higher and pharmacy technician subscribers. Log in to your Pharmacist’s Letter or Pharmacy Technician’s Letter account and look for the title of this podcast in the list of available CE courses. None of the speakers have anything to disclose. Claim Credit ****** Clinical Resources from Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:  Article: Anticipate Earlier CGM Use for DiabetesChart: Continuous Glucose MonitoringDon’t miss out! Subscribe today to stay ahead with trusted insights and tools.  🎓 Are you a student? Great news—students can access a free version of Pharmacist’s Letter. 🗪 Send us Fan Mail Email us: [email protected].  The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment.  Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here. Learn more about our product offerings at trchealthcare.com.

New guidelines for moderate to severe Crohn disease help streamline more advanced therapy options, such as biologics and JAK inhibitors. In this episode, TRC Healthcare Assistant Editor and Clinical Pharmacist Gina Corley, PharmD, walks through the latest guideline updates for moderate to severe Crohn disease. She breaks down advanced therapy options such as biologics and JAK inhibitors, discusses how factors like prior biologic exposure shape treatment decisions, and where immunomodulators and steroids fit in. This is an excerpt from our March 2026 Pharmacy Essential Updates continuing education webinar series. 🏷️ Use code cc1026 at checkout for 10% off a new or upgraded subscription. ****** CE Information: TRC Healthcare offers CE credit for this podcast for pharmacist subscribers at our platinum level or higher and pharmacy technician subscribers. Log in to your Pharmacist’s Letter or Pharmacy Technician’s Letter account and look for the title of this podcast in the list of available CE courses. None of the speakers have anything to disclose. Claim Credit ****** Clinical Resources from Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:  Article: Prioritize Advanced Therapies in Crohn DiseaseChart: Biologics and JAK Inhibitors for Moderate to Severe Crohn DiseaseDon’t miss out! Subscribe today to stay ahead with trusted insights and tools.  🎓 Are you a student? Great news—students can access a free version of Pharmacist’s Letter. 🗪 Send us Fan Mail Email us: [email protected].  The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment.  Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here. Learn more about our product offerings at trchealthcare.com.

Updated COPD guidelines are reshaping how soon patients start daily inhalers—and what therapies make the most sense based on symptoms and risk. In this episode, TRC Healthcare Associate Editor and Clinical Pharmacist Don Weinberger, PharmD, PMSP, reviews practical, guideline-based strategies for treating and managing chronic obstructive pulmonary disease (COPD). Don highlights common factors that increase exacerbation risk and explains how current recommendations aim to better match therapy to patient needs. He also clarifies key differences between COPD and asthma, walks through the main goals of COPD management, and reviews where short- and long-acting bronchodilators, as well as inhaled corticosteroids, fit into care. The discussion includes when to escalate treatment, common inhaler technique mistakes that limit effectiveness, and non-drug strategies that can help keep patients out of the hospital. In this episode, you’ll hear about: How updated guidelines approach COPD treatment and escalationWhen to use short-acting inhalers, dual bronchodilators, or triple therapyCommon inhaler technique errors that increase exacerbation riskThe role of smoking cessation, vaccinations, and adherence in improving outcomesThis is an excerpt from our February 2026 Pharmacy Essential Updates continuing education webinar series. 🏷️ Use code cc1026 at checkout for 10% off a new or upgraded subscription. ****** CE Information: TRC Healthcare offers CE credit for this podcast for pharmacist subscribers at our platinum level or higher and pharmacy technician subscribers. Log in to your Pharmacist’s Letter or Pharmacy Technician’s Letter account and look for the title of this podcast in the list of available CE courses. None of the speakers have anything to disclose. Claim Credit ****** Clinical Resources from Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:  Article: Clear the Air With New COPD GuidelinesChart: Inhaled Medications for COPDAlgorithm: Improving COPD CareAlgorithm: Stepwise Treatment of Asthma (12 Years and Older)Algorithm: Stepwise Treatment of Asthma (Under 12 Years of Age)Don’t miss out! Subscribe today to stay ahead with trusted insights and tools.  🎓 Are you a student? Great news—students can access a free version of Pharmacist’s Letter. 🗪 Send us Fan Mail Email us: [email protected].  The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment.  Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here. Learn more about our product offerings at trchealthcare.com.

Blood pressure is one of the most commonly measured — and most commonly misread — vitals in healthcare. In this episode, TRC Healthcare Associate Editor and Clinical Pharmacist Vickie Danaher, PharmD, discusses how pharmacists and pharmacy technicians can help patients better manage hypertension. She goes over how to choose the right home blood pressure monitor, ways to use it correctly, and tips for getting the most accurate readings. This is an excerpt from our March 2026 Pharmacy Essential Updates continuing education webinar series. 🏷️ Use code cc1026 at checkout for 10% off a new or upgraded subscription. ****** CE Information: TRC Healthcare offers CE credit for this podcast for pharmacist subscribers at our platinum level or higher and pharmacy technician subscribers. Log in to your Pharmacist’s Letter or Pharmacy Technician’s Letter account and look for the title of this podcast in the list of available CE courses. None of the speakers have anything to disclose. Claim Credit ****** Clinical Resources from Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:  Article: Avoid Common Blood Pressure Measurement ErrorsChecklist: Measuring Blood PressureDon’t miss out! Subscribe today to stay ahead with trusted insights and tools.  🎓 Are you a student? Great news—students can access a free version of Pharmacist’s Letter. 🗪 Send us Fan Mail Email us: [email protected].  The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment.  Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here. Learn more about our product offerings at trchealthcare.com.

Male pattern baldness is more than a cosmetic concern – and patients often turn to the pharmacy first for answers. In this episode, TRC Healthcare Associate Editor and Clinical Pharmacist Don Weinberger, PharmD, PMSP, discusses treating male pattern baldness. He reviews the underlying mechanism of hair loss and compares evidence-based treatment options, including oral finasteride, topical minoxidil, and more. Don also provides practical counseling points, including adverse effects, expected timelines for hair regrowth, and why the effects are typically not permanent once treatment is stopped.  This is an excerpt from our January 2026 Pharmacy Essential Updates continuing education webinar series. 🏷️ Use code cc1026 at checkout for 10% off a new or upgraded subscription.  ****** CE Information: TRC Healthcare offers CE credit for this podcast for pharmacist subscribers at our platinum level or higher and pharmacy technician subscribers. Log in to your Pharmacist’s Letter or Pharmacy Technician’s Letter account and look for the title of this podcast in the list of available CE courses. None of the speakers have anything to disclose. Claim Credit ****** Clinical Resources from Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:  Article: Get to the Root of Male Pattern Baldness TreatmentsChart: Treatment and Prevention of Hair LossPodcast: Rumor vs Truth – Hair Loss TreatmentsDon’t miss out! Subscribe today to stay ahead with trusted insights and tools.  🎓 Are you a student? Great news—students can access a free version of Pharmacist’s Letter. 🗪 Send us Fan Mail Email us: [email protected].  The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment.  Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here. Learn more about our product offerings at trchealthcare.com.

A new oral option is changing the GLP-1 landscape for weight loss, along with raising questions about efficacy, dosing, and when switching products makes sense. In this episode, TRC Healthcare Associate Editor and Clinical Pharmacist Vickie Danaher, PharmD discusses how semaglutide became the first FDA-approved oral GLP-1 agonist for obesity. She breaks down how it works, how it compares to injectable options, and dosing considerations for patients. Vickie also walks through key counseling points around administration, side effects, cost, and product mix-ups, and offers practical guidance on when switching between injectable and oral semaglutide may or may not be the right choice. This is an excerpt from our February 2026 Pharmacy Essential Updates continuing education webinar series. 🏷️ Use code cc1026 at checkout for 10% off a new or upgraded subscription.  ****** CE Information: TRC Healthcare offers CE credit for this podcast for pharmacist subscribers at our platinum level or higher and pharmacy technician subscribers. Log in to your Pharmacist’s Letter or Pharmacy Technician’s Letter account and look for the title of this podcast in the list of available CE courses. None of the speakers have anything to disclose. Claim Credit ****** Clinical Resources from Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:  Article: Explain How New ORAL Semaglutide Stacks Up for Weight LossInteractive Chart: GLP-1 and GIP/GLP-1 Receptor Agonist Interactive Comparison ChartResource: Comparison of Weight Loss ProductsDon’t miss out! Subscribe today to stay ahead with trusted insights and tools.  🎓 Are you a student? Great news—students can access a free version of Pharmacist’s Letter. 🗪 Send us Fan Mail Email us: [email protected].  The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment.  Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here. Learn more about our product offerings at trchealthcare.com.

Opioid overdoses remain a leading cause of preventable death - and pharmacy teams are on the front lines of response. In this episode, TRC Healthcare Associate Editor and Clinical Pharmacist Don Weinberger, PharmD, PMSP, discusses how to recognize opioid overdose, compares naloxone and nalmefene options including the new nalmefene auto-injector, and shares tips for counseling patients and caregivers on using opioid reversal agents effectively. This is an excerpt from our December 2025 Pharmacy Essential Updates continuing education webinar series. ****** CE Information: TRC Healthcare offers CE credit for this podcast for pharmacist subscribers at our platinum level or higher and pharmacy technician subscribers. Log in to your Pharmacist’s Letter or Pharmacy Technician’s Letter account and look for the title of this podcast in the list of available CE courses. None of the speakers have anything to disclose. Claim Credit ****** Clinical Resources from Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:  Article: Boost Access to Naloxone or NalmefeneFAQ: Meds for Opioid OverdoseToolbox: Appropriate Opioid UseChart: Opioid Reversal Agents Quick Start GuideFAQ: Management of Opioid Use DisorderDon’t miss out! Subscribe today to stay ahead with trusted insights and tools.  🏷️ Use code cc1026 at checkout for 10% off a new or upgraded subscription. 🎓 Are you a student? Great news—students can access a free version of Pharmacist’s Letter. 🗪 Send us Fan Mail Email us: [email protected].  The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment.  Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here. Learn more about our product offerings at trchealthcare.com.